Denali Therapeutics Inc (DNLI) Ownership

16.15 ↓0.01 (-0.06%)

As of May 2, 2024, 10:23am EST.

Institutions
Mutual Funds

Institutional Ownership

Baillie Gifford & Co Limited. is the biggest individual institutional holder of Denali Therapeutics Inc (DNLI), owning a total of 14.3 million shares. Combined, the top 27 institutional holders of DNLI own 68.55% of the company with a total of 95.3 million shares.

In the latest ownership report on December 31st 2023, the top 27 institutional holders increased their combined ownership of DNLI by 3.2 million shares. 9 institutions bought 4,382,080 total additional shares and increased their ownership by an average of 7.72%. However 6 institutions sold 1,172,043 total shares and decreased their ownership by an average of 4.33%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Denali Therapeutics increased by a net total of 3,210,037 in the latest quarter.

Institution Ownership Chart

Latest Institutional Ownership Changes

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
Baillie Gifford & Co Limited.	10.248%	-2.863%	14,260,724	-420,303	2023-12-31
BlackRock Inc	8.295%	6.046%	11,543,446	658,150	2023-12-31
Vanguard Group Inc	7.786%	2.234%	10,834,483	236,702	2023-12-31
Wellington Management Company LLP	5.228%	-0.195%	7,274,717	-14,243	2023-12-31
Temasek Holdings Ltd.	4.955%	0.000%	6,895,992	0	2023-12-31
Crestline Management LP	4.068%	-5.033%	5,660,732	-300,000	2023-12-31
State Street Corporation	3.942%	28.316%	5,485,948	1,210,620	2023-12-31
Capital Research Global Investors	2.091%	1.014%	2,909,528	29,205	2023-12-31
Geode Capital Management, LLC	1.911%	5.034%	2,659,296	127,461	2023-12-31
Baker Bros Advisors LP	1.874%	13.752%	2,607,196	315,193	2023-12-31
T. Rowe Price Associates, Inc.	1.850%	-10.983%	2,574,321	-317,629	2023-12-31
Bank of New York Mellon Corp	1.344%	-4.739%	1,870,627	-93,061	2023-12-31
Marshall Wace Asset Management Ltd	1.198%	0.000%	1,667,397	1,667,397	2023-12-31
Credit Suisse First Boston (CSFB)	1.133%	0.569%	1,576,221	8,912	2023-12-31
Federated Hermes Inc	0.972%	0.000%	1,351,900	0	2023-12-31
Casdin Capital, LLC	0.934%	0.000%	1,300,000	0	2023-12-31
Gilder Gagnon Howe & CO LLC	0.876%	-2.151%	1,219,392	-26,807	2023-12-31
NORGES BANK	0.828%	12.540%	1,152,646	128,440	2023-12-31
Yiheng Capital LLC	0.827%	0.000%	1,150,684	0	2023-12-31

Top Institutions

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
Baillie Gifford & Co Limited.	10.248%	-2.863%	14,260,724	-420,303	2023-12-31
BlackRock Inc	8.295%	6.046%	11,543,446	658,150	2023-12-31
Vanguard Group Inc	7.786%	2.234%	10,834,483	236,702	2023-12-31
Wellington Management Company LLP	5.228%	-0.195%	7,274,717	-14,243	2023-12-31
Temasek Holdings Ltd.	4.955%	0.000%	6,895,992	0	2023-12-31
Crestline Management LP	4.068%	-5.033%	5,660,732	-300,000	2023-12-31
State Street Corporation	3.942%	28.316%	5,485,948	1,210,620	2023-12-31
Capital Research Global Investors	2.091%	1.014%	2,909,528	29,205	2023-12-31
Geode Capital Management, LLC	1.911%	5.034%	2,659,296	127,461	2023-12-31
Flagship Ventures Management, Inc.	1.883%	0.000%	2,619,968	0	2023-09-30
Baker Bros Advisors LP	1.874%	13.752%	2,607,196	315,193	2023-12-31
T. Rowe Price Associates, Inc.	1.850%	-10.983%	2,574,321	-317,629	2023-12-31
ARCH VENTURE CORP	1.877%	-29.983%	2,568,749	-1,100,000	2023-03-31
Bank of New York Mellon Corp	1.344%	-4.739%	1,870,627	-93,061	2023-12-31
Marshall Wace Asset Management Ltd	1.198%	0.000%	1,667,397	1,667,397	2023-12-31
Credit Suisse First Boston (CSFB)	1.133%	0.569%	1,576,221	8,912	2023-12-31
Citadel Advisors Llc	1.000%	3,870.550%	1,374,325	1,339,712	2023-03-31
Federated Hermes Inc	0.972%	0.000%	1,351,900	0	2023-12-31
Casdin Capital, LLC	0.934%	0.000%	1,300,000	0	2023-12-31
Gilder Gagnon Howe & CO LLC	0.876%	-2.151%	1,219,392	-26,807	2023-12-31
NORGES BANK	0.828%	12.540%	1,152,646	128,440	2023-12-31
Yiheng Capital LLC	0.827%	0.000%	1,150,684	0	2023-12-31
Northern Trust Corp	0.808%	2.482%	1,116,742	27,044	2023-09-30
Morgan Stanley - Brokerage Accounts	0.779%	89.219%	1,076,886	507,764	2023-06-30
FMR Inc	0.766%	-1.978%	1,058,497	-21,360	2023-09-30
Charles Schwab Investment Management Inc	0.538%	-0.088%	730,880	-642	2022-09-30
Goldman Sachs Group Inc	0.536%	73.092%	728,272	307,530	2022-09-30

Mutual Fund Ownership

Scottish Mortgage Ord is the biggest individual fund holder of Denali Therapeutics Inc (DNLI), owning a total of 6.5 million shares. Combined, the top 28 mutual fund holders of DNLI own 41.95% of the company with a total of 59.4 million shares.

In the latest ownership report on March 31st 2024, the top 28 fund holders increased their combined ownership of DNLI by 3.3 million shares. 5 funds bought 3,361,544 total additional shares and increased their ownership by an average of 30.58%. However 2 funds sold 28,698 total shares and decreased their ownership by an average of 0.58%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Denali Therapeutics increased by a net total of 3,332,846 in the latest report.

Mutual Funds Chart

Latest Mutual Fund Ownership Changes

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
American Funds SMALLCAP World A	2.996%	69.903%	4,269,259	1,756,500	2024-03-31
SPDR® S&P Biotech ETF	2.556%	0.536%	3,642,933	19,431	2024-03-31
Vanguard Small Cap Index	1.856%	-0.973%	2,645,203	-25,977	2024-03-31
Vanguard Institutional Extnd Mkt Idx Tr	1.301%	1.324%	1,854,474	24,231	2024-03-31
Vanguard Small Cap Growth Index Inv	1.050%	-0.182%	1,496,785	-2,721	2024-03-31
American Funds New Economy A	0.801%	0.000%	1,141,800	1,141,800	2024-03-31
T. Rowe Price Health Sciences	0.657%	81.128%	936,767	419,582	2024-03-31

Top Mutual Funds

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
Scottish Mortgage Ord	4.582%	0.074%	6,529,223	4,831	2024-02-29
Vanguard Health Care Inv	3.579%	0.000%	5,100,454	0	2023-12-31
American Funds SMALLCAP World A	2.996%	69.903%	4,269,259	1,756,500	2024-03-31
SPDR® S&P Biotech ETF	2.556%	0.536%	3,642,933	19,431	2024-03-31
Baillie Gifford US Equity Growth	2.464%	0.000%	3,510,877	0	2024-02-29
Vanguard US Growth Investor	2.464%	-3.939%	3,510,877	-143,973	2023-12-31
Vanguard Total Stock Mkt Idx Inv	2.282%	-0.407%	3,252,243	-13,287	2024-02-29
Vanguard Instl Ttl Stck Mkt Idx Tr	2.304%	1.433%	3,184,286	44,984	2023-03-31
iShares Russell 2000 ETF	2.060%	0.627%	2,936,209	18,298	2024-03-28
Vanguard Small Cap Index	1.856%	-0.973%	2,645,203	-25,977	2024-03-31
Vanguard Institutional Extnd Mkt Idx Tr	1.301%	1.324%	1,854,474	24,231	2024-03-31
Baillie Gifford American B Inc	1.127%	-3.972%	1,606,547	-66,455	2024-02-29
Vanguard Extended Market Index Investor	1.107%	-0.017%	1,521,860	-254	2023-08-31
Vanguard Small Cap Growth Index Inv	1.050%	-0.182%	1,496,785	-2,721	2024-03-31
CS (Lux) Digital Health Equity SB USD	0.982%	0.000%	1,400,000	0	2024-02-29
US Small-Cap Growth II Equity Comp	0.861%	-0.319%	1,197,891	-3,830	2023-12-31
T. Rowe Price New Horizons	0.861%	-0.319%	1,197,891	-3,830	2023-12-31
Fidelity Small Cap Index	0.838%	1.635%	1,194,834	19,222	2024-01-31
American Funds New Economy A	0.801%	0.000%	1,141,800	1,141,800	2024-03-31
Fidelity® Small Cap Index	0.824%	2.773%	1,138,669	30,726	2023-10-31
iShares Russell 2000 Growth ETF	0.728%	-0.116%	1,037,976	-1,207	2024-03-28
Polar Capital Biotech S Inc	0.706%	-2.500%	975,000	-25,000	2023-11-30
Federated Hermes Kaufmann Small Cap Grow	0.660%	0.000%	940,000	0	2023-12-31
Federated Hermes Kaufmann Small Cap A	0.660%	0.000%	940,000	0	2023-12-31
T. Rowe Price Health Sciences	0.657%	81.128%	936,767	419,582	2024-03-31
iShares Biotechnology ETF	0.591%	0.000%	841,999	0	2024-03-28
Baillie Gifford Managed B Acc	0.555%	-3.334%	760,281	-26,219	2023-05-31
BNY Mellon Sm/Md Cp Gr I	0.499%	-1.313%	678,003	-9,022	2022-10-31